We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

27 hedge funds and large institutions have $11.9M invested in Cytosorbents Corp in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

950% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 2

205% more capital invested

Capital invested by funds: $3.92M → $11.9M (+$8.02M)

200% more funds holding

Funds holding: 9 → 27 (+18)

4% more call options, than puts

Call options by funds: $230K | Put options by funds: $222K

Holders
27
Holders Change
+18
Holders Change %
+200%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
2
Reduced
–
Closed
2
Calls
$230K
Puts
$222K
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.55M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.31M
3
AIG
American International Group
New York
+$899K
4
Millennium Management
Millennium Management
New York
+$523K
5
Morgan Stanley
Morgan Stanley
New York
+$493K

Top Sellers

Rank Fund Capital Flow
1
SFM
Signet Financial Management
New Jersey
-$2.87M
2
Bank of America
Bank of America
North Carolina
-$8K

CTSO Hedge Fund Activity: Q1 2015 in Review

27 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2015, worth a combined $11.9M — up 205% from $3.92M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new CTSO positions and 2 closed out — a net gain of 19 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $2.55M. The largest seller was Signet Financial Management, exiting entirely with an estimated $2.87M sold.

  • 27 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2015, up from 9 in Q4 2014.
  • Funds reported $11.9M of Cytosorbents Corp stock for Q1 2015, up 205% quarter-over-quarter.
  • 21 funds opened new Cytosorbents Corp positions in Q1 2015 and 2 closed out, a net change of +19 holders.
  • The largest Cytosorbents Corp buyer in Q1 2015 was Vanguard Group, an estimated $2.55M added.
  • The largest Cytosorbents Corp seller in Q1 2015 was Signet Financial Management, an estimated $2.87M sold.

Based on aggregated 13F filings for Q1 2015.